Momentum is picking up for diabetes-focused biotech MannKind (MNKD). Shares surged 36% this week after MannKind’s presentation at the American Diabetes Association’s conference …
Penny stocks, you either love them or you hate them. One of the obvious draws of these stocks trading for under $5 per …
Of all the controversial plays on Wall Street, penny stocks take the cake. The risk-tolerant flock to these names as the potential for …
Biotechs on a tear have been a theme in 2020. Most have taken off on the hope of solving the COVID-19 vaccine or …
The stock market is heating up, and some Wall Street bulls are turning even more positive. Among those adapting an increasingly bullish approach …
Which stocks are leading the pack out on Wall Street? Biotechs.
In the world of biotechs, all it takes is a single piece of good news to change the narrative. This has been exemplified …
It has been a rough five years for investors of diabetes-focused biotech MannKind (MNKD). Over the period, shares of the company have declined …
It has been almost three months since the coronavirus-driven volatility hit the global economy, and the market continues to rapidly move into both …
COVID-19 vaccine development across the globe is charging ahead with over 120 possible vaccines in progress. Healthcare companies of all sizes have thrown …
